Chronic Lymphocytid Leukemia - New Discoveries and Options for Patients

October 3, 2012 – 7:00 pm
McNally Robinson Booksellers, 1120 Grant Avenue, Winnipeg
Seating is limited, RSVP to: eileanmckenzie@cancercare.mb.ca, (204) 787-2814

Chronic Lymphocytic Leukemia is a cancer of the white blood cells. It is the mostly widely diagnosed type of leukemia in the Western world, mostly affecting older men and has a poor survival rate. As the Baby Boomer generation grows older, the incidence of CLL will increase.

In the new era of personalized medicine, what new diagnostic tests will improve detection at the earliest stages? What research discoveries will pave the way to new treatments and improve survivorship? What clinical trials are being conducted in Manitoba? Join us in a lively and open discussion on CLL with Canada’s leading scientists, clinicians, patient advocates and nurses on this important disease.

Experts

Dr. James B Johnston
Clinical Director of Manitoba CLL Tumour Bank
Hematologist/Oncologist CancerCare Manitoba
Senior Scientist and Associate Director, Clinical Affairs,
Manitoba Institute of Cell Biology
Professor of Medicine, University of Manitoba

Dr. Versha Banerji
Senior Scientist Manitoba Institute of Cell Biology
Hematologist/Oncologist CancerCare Manitoba
Associate Professor, Biochemistry & Medical Genetics,
Faculty of Medicine, University of Manitoba

Dr. Aaron Marshall
Professor, Immunology, Biochemistry & Medical Genetics
Canada Research Chair in Molecular Immunology
Faculty of Medicine, University of Manitoba

Dr. Cynthia Toze
Member, Leukemia/BMT Program of British Columbia,
Clinical Associate Professor of Medicine, BC Cancer Agency
Gordon & Leslie Diamond Health Care Center,
Hematology Administration

Dan Skwarchuk
Executive Director, Health Services Integration
Winnipeg Regional Health Authority

Moderator

Dr. Spencer Gibson
Director, Manitoba Institute of Cell Biology
Professor and Manitoba Chair; Biochemistry, Medical Genetics, Immunology
University of Manitoba